The best cutoff of CA125 for predicting the lymph node metastasis rose to 30 U/mL from 25 U/mL in patients ≤ 50 years of age or with premenopause. This evidence concerns the gene MUC16 and metastatic malignant neoplasm in the lymph nodes.